Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

INDUSTRY 10OTHER 9NETWORK 7OTHER_GOV 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 6Esophageal Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Nasopharyngeal Carcinoma 5Lung Neoplasms 5Nasopharyngeal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Breast Neoplasms 3Neoplasms, Germ Cell and Embryonal 2Head and Neck Neoplasms 2Gallbladder Neoplasms 2Carcinoma, Squamous Cell 2Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Recurrence 1Ovarian Neoplasms 1Oesophagogastric Cancer 1Neoplasms, Squamous Cell 1Neoplasm Metastasis 1Mesothelioma, Malignant 1Locally Advanced Cervical Cancer 1Human Papillomavirus (HPV)-Positive Oropharyngeal Cancer 1Gastro-enteropancreatic neuroendocrine tumor 1Fibrosis Of Extraocular Muscles, Congenital, 3A, with or without Extraocular Involvement 1Endometrial Neoplasms 1EGFR Positive Non-small Cell Lung Cancer 1Carcinoma, Ovarian Epithelial 1

Interventions

pembrolizumab 1dostarlimab 1Surgical Procedures, Operative 1Sentinel Lymph Node Biopsy 1Paclitaxel 1Motivational Interviewing 1Metformin 1Medroxyprogesterone Acetate 1Laparotomy 1Laparoscopy 1Indocyanine Green 1Exercise 1ETC-159 1Diet 1Cisplatin 1Carboplatin 1CP protocol 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER_GOV × Endometrial Neoplasms × Cisplatin × Clear all
NCT06066216 2024-01-23

Cadonilimab (AK104) Plus Chemotherapy in Patients With Recurrent or Advanced Endometrial Cancer

Fujian Cancer Hospital

Phase 2 Not yet recruiting
45 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡